Case 20-2008: A 57-year-old woman with abdominal pain and weakness after gastric bypass surgery

New England Journal of Medicine

Volumn 358, Issue 26, 2008, Pages 2813-

  Bonkovsky, Herbert L ^a,b,c,d   Siao, Peter ^e,f   Roig, Zulmarie ^e,f   Hedley Whyte, E Tessa ^e,f   Flotte, Thomas J ^e,f  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b CAROLINAS MEDICAL CENTER   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; CORTICOSTEROID; COTRIMOXAZOLE; HEMATIN; LEVOFLOXACIN; OXYCODONE; PARACETAMOL; PHENAZOPYRIDINE; PHENYLEPHRINE; PHENYTOIN; THEOPHYLLINE; VANCOMYCIN; HEME; PORPHYRIN;

ABDOMINAL PAIN; ACUTE INTERMITTENT PORPHYRIA; ADRENAL TUMOR; ADULT; ARTICLE; ASYSTOLE; BRADYCARDIA; BRAIN DISEASE; CASE REPORT; CHOLECYSTECTOMY; FEMALE; GALLSTONE; HUMAN; HYPOTENSION; KLEBSIELLA PNEUMONIAE; LIVER BIOPSY; LUMBAR PUNCTURE; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PRIORITY JOURNAL; STOMACH BYPASS; TONIC CLONIC SEIZURE; URINARY TRACT INFECTION; URINE CULTURE; VENTILATOR ASSOCIATED PNEUMONIA; WEAKNESS; ACUTE DISEASE; BIOSYNTHESIS; BRAIN; CHEMISTRY; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; DIFFERENTIAL DIAGNOSIS; GUILLAIN BARRE SYNDROME; MIDDLE AGED; PATHOLOGY; PORPHYRIA; POSTOPERATIVE COMPLICATION; QUADRIPLEGIA; SURAL NERVE; URINE;

ABDOMINAL PAIN; ACUTE DISEASE; BRAIN; CHOLECYSTECTOMY; DIAGNOSIS, DIFFERENTIAL; FEMALE; GASTRIC BYPASS; GUILLAIN-BARRE SYNDROME; HEME; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PORPHYRIAS; PORPHYRINS; POSTOPERATIVE COMPLICATIONS; QUADRIPLEGIA; SURAL NERVE; URINE;

EID: 45949097846     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcpc0803190     Document Type: Article

References (24)

1. Bonkovsky HL, Schady W. The neurological manifestations of acute porphyria. Semin Liver Dis 1982;2:108-24.
2. Hahn M, Bonkovsky H. Disorders of porphyrin metabolism. In: Wu G, Israel J, eds. Diseases of the liver and bile ducts: a practical guide to diagnosis and treatment. Totowa, NJ: Humana Press, 1998:249-72.
3. Soonawalla ZF, Orug T, Badminton MN, et al. Liver transplantation as a cure for acute intermittent porphyria. Lancet 2004;363:705-6.
4. DeMaria EJ. Bariatric surgery for morbid obesity. N Engl J Med 2007;356:2176-83.
5. Kolluri S, Sadlon TJ, May BK, Bonkovsky HL. Haem repression of the housekeeping 5-aminolaevulinic acid synthase gene in the hepatoma cell line LMH. Biochem J 2005;392:173-80.
6. Bonkowsky HL, Tschudy DP, Collins A, Doherty JM. Control of -aminolevulinic acid synthetase and tyrosine aminotransferase in tumors and livers of tumor-bearing rats. J Natl Cancer Inst 1973;50:1215-25.
7. Varone CL, Canepa ET, Llambias EB, Grinstein M. Glucose inhibits phenobarbital-induced delta-aminolevulinate synthase expression in normal but not in diabetic rat hepatocytes. Biochem Cell Biol 1996;74:271-81.
8. Handschin C, Lin J, Rhee J, et al. Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1alpha. Cell 2005;122:505-15.
9. Fraser DJ, Podvinec M, Kaufmann MR, Meyer UA. Drugs mediate the transcriptional activation of the 5-aminolevulinic acid synthase (ALAS1) gene via the chicken xenobiotic-sensing nuclear receptor (CXR). J Biol Chem 2002;277:34717-26.
10. Lambrecht RW, Gildemeister OS, Williams A, Pepe JA, Tortorelli KD, Bonkovsky HL. Effects of selected antihypertensives and analgesics on hepatic porphyrin accumulation: implications for clinical porphyria. Biochem Pharmacol 1999;58:887-96.
11. Bonkovsky HL. Porphyrin and heme metabolism and the porphyrias. In: Zakim D, Boyer TD, eds. Hepatology: a textbook of liver disease. 2nd ed. Philadelphia: W.B. Saunders, 1990:378-424.
12. Kalman DR, Bonkovsky HL. Management of acute attacks in the porphyrias. Clin Dermatol 1998;16:299-306.
13. Bonkowsky HL, Tschudy A, Collins J, et al. Repression of the overproduction of porphyrin precursors in acute intermittent porphyria by intravenous infusions of hematin. Proc Natl Acad Sci U S A 1971;68:2725-9.
14. Bonkovsky HL, Healey JF, Lourie AN, Gerron GG. Intravenous heme-albumin in acute intermittent porphyria: evidence for repletion of hepatic hemoproteins and regulatory heme pools. Am J Gastroenterol 1991;86:1050-6.
15. Anderson KE, Bloomer JR, Bonkovsky HL, et al. Recommendations for the diagnosis and treatment of the acute porphyrias. Ann Intern Med 2005;142:439-50. [Erratum, Ann Intern Med 2005;143:316.]
16. Litman DA, Correia MA. L-tryptophan: a common denominator of biochemical and neurological events of acute hepatic porphyria? Science 1983;222:1031-3.
17. Peterson A, Bossenmaier I, Cardinal R, Watson CJ. Hematin treatment of acute porphyria: early remission of an almost fatal relapse. JAMA 1976;235:520-2.
18. Denny-Brown D, Sciarra D. Changes in the nervous system in acute porphyria. Brain 1945;68:1-16.
19. Albers JW, Fink JK. Porphyric neuropathy. Muscle Nerve 2004;30:410-22.
20. Windebank AJ, Bonkovsky HL. Porphyric neuropathy. In: Dyck PJ, Thomas PK, eds. Peripheral neuropathy. 4th ed. Philadelphia: Elsevier Saunders, 2005:1883-92.
21. Mustajoki P. Normal erythrocyte uroporphyrinogen I synthase in a kindred with acute intermittent porphyria. Ann Intern Med 1981;95:162-6.
22. Meola T, Lim HW. The porphyrias. Dermatol Clin 1993;11:583-96.
23. Maynard B, Peters MS. Histologic and immunofluorescence study of cutaneous porphyrias. J Cutan Pathol 1992;19:40-7.
24. Baart de la Faille H, Bijlmer-Iest JC, van Hattum J, Koningsberger J, Rademakers LH, van Weelden H. Erythropoietic protoporphyria: clinical aspects with emphasis on the skin. Curr Probl Dermatol 1991;20:123-34.